MAXPHARMA
0471.830.863 · rovalta.com · 22/09/2026
ACTIVE
MAXPHARMA
Financial year 2025 · closed on 31/12/2025
Net result
15,3 k €
+160.6% YoY
Gross margin
113 k €
+27.5% YoY
Equity
284,7 k €
-1.6% YoY
Workforce
1,9 ETP
-29.6% YoY
Overview
What does MAXPHARMA do?
MAXPHARMA is a Public limited company incorporated in 2000. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Etterbeek. It employs on average 1,9 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0471.830.863
Incorporation
05/05/2000
Legal form
Public limited company
Registered office
Chaussée de Wavre 736
1040 Etterbeek · BruxellesSee on map
1040 Etterbeek · BruxellesSee on map
Contributed capital
61 973,38 €
Latest accounts
31/12/2025
Average workforce
1,9 ETP
Activities (NACE)
Joint committees (1)
- 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Gross margin | 113 k € | +27.5% | 88,7 k € | -30.5% | 127,5 k € | +3.0% | 123,8 k € | -45.1% | 225,5 k € | +51.4% | 149 k € | -22.1% | 191,3 k € | +60.4% | 119,2 k € | +137% | 50,3 k € | -19.7% | 62,6 k € | +12.5% | 55,6 k € | -1.8% | 56,7 k € | -4.8% | 59,5 k € | -10.3% | 66,4 k € | -23.4% | 86,7 k € | -11.1% | 97,5 k € | +10.8% | 88 k € | -6.0% | 93,6 k € | -0.3% | 93,8 k € | +20.1% | 78,1 k € |
| EBITDA | 43,4 k € | +574% | -9,2 k € | -152% | 17,5 k € | -24.4% | 23,2 k € | -82.2% | 130,7 k € | +134% | 55,8 k € | -35.5% | 86,5 k € | -27.3% | 119 k € | +137% | 50,3 k € | -19.7% | 62,6 k € | +19.1% | 52,5 k € | -7.3% | 56,7 k € | -4.8% | 59,5 k € | -7.2% | 64,1 k € | -26.1% | 86,7 k € | -11.1% | 97,5 k € | +10.8% | 88 k € | -6.0% | 93,6 k € | -0.2% | 93,8 k € | +20.3% | 77,9 k € |
| Operating result | 28,5 k € | +216% | -24,6 k € | -8352% | 297,6 € | -49.9% | 593,9 € | -99.4% | 102,8 k € | +251% | 29,3 k € | -50.3% | 59 k € | -47.1% | 111,4 k € | +339% | 25,4 k € | -33.0% | 37,9 k € | +36.5% | 27,7 k € | -14.7% | 32,5 k € | -8.5% | 35,6 k € | -11.4% | 40,2 k € | -36.2% | 62,9 k € | -15.0% | 74 k € | +13.7% | 65,1 k € | -7.6% | 70,5 k € | +26.2% | 55,9 k € | -7.2% | 60,2 k € |
| Net result | 15,3 k € | +161% | -25,2 k € | -546% | -3,9 k € | +4.6% | -4,1 k € | -105% | 75 k € | +344% | 16,9 k € | -57.0% | 39,3 k € | -52.6% | 82,9 k € | +612% | 11,6 k € | -45.6% | 21,4 k € | +157% | 8,3 k € | -33.2% | 12,5 k € | -8.7% | 13,6 k € | -20.1% | 17,1 k € | -38.8% | 27,9 k € | -15.7% | 33,1 k € | +55.9% | 21,2 k € | -12.4% | 24,2 k € | +73.0% | 14 k € | -36.4% | 22 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 284,7 k € | -1.6% | 289,5 k € | -8.0% | 314,7 k € | -1.2% | 318,6 k € | -4.7% | 334,2 k € | +29.0% | 259,1 k € | -3.4% | 268,2 k € | +17.2% | 228,9 k € | +56.8% | 146 k € | -37.4% | 233,4 k € | +10.1% | 212 k € | +4.1% | 203,6 k € | +6.5% | 191,2 k € | -2.8% | 196,6 k € | +4.8% | 187,6 k € | +11.8% | 167,7 k € | +17.5% | 142,7 k € | +10.2% | 129,5 k € | +14.3% | 113,4 k € | +5.5% | 107,4 k € |
| Total assets | 427 k € | +7.2% | 398,2 k € | -3.0% | 410,6 k € | -17.4% | 497 k € | +14.4% | 434,4 k € | +0.7% | 431,6 k € | -10.5% | 482 k € | +13.2% | 425,9 k € | -10.3% | 475 k € | -0.6% | 478,1 k € | +1.1% | 473 k € | -6.1% | 503,9 k € | -9.5% | 556,7 k € | -8.3% | 607,4 k € | -5.6% | 643,1 k € | -4.2% | 671,4 k € | -4.6% | 703,4 k € | -4.0% | 732,9 k € | -3.4% | 759 k € | +19.0% | 637,8 k € |
| Cash | 118,1 k € | -26.4% | 160,5 k € | +14.3% | 140,4 k € | -17.7% | 170,6 k € | +19.3% | 143 k € | +32.9% | 107,6 k € | +10.6% | 97,3 k € | +62.2% | 60 k € | +39.4% | 43 k € | +51.5% | 28,4 k € | +315% | 6,8 k € | +54.7% | 4,4 k € | -64.1% | 12,3 k € | +82.5% | 6,8 k € | -21.8% | 8,6 k € | -25.1% | 11,5 k € | -2.9% | 11,9 k € | -47.2% | 22,5 k € | +84.6% | 12,2 k € | +1.0% | 12,1 k € |
| Debts | 142,3 k € | +31.0% | 108,6 k € | +13.2% | 95,9 k € | -46.2% | 178,4 k € | +78.0% | 100,2 k € | -41.9% | 172,4 k € | -19.3% | 213,7 k € | +8.5% | 196,9 k € | -40.1% | 329 k € | +34.4% | 244,7 k € | -6.1% | 260,5 k € | -12.5% | 297,9 k € | -17.1% | 359,2 k € | -11.0% | 403,7 k € | -11.4% | 455,6 k € | -9.5% | 503,7 k € | -9.9% | 559 k € | -6.7% | 599,3 k € | -4.9% | 630,1 k € | +19.2% | 528,6 k € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 1,9 ETP | -29.6% | 2,7 ETP | +17.4% | 2,3 ETP | 0.0% | 2,3 ETP | 0.0% | 2,3 ETP | 0.0% | 2,3 ETP | +9.5% | 2,1 ETP | – | – | – | – | – | – | – | – | – | – | – | – | – | |||||||||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 1 active · 14 ended
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 01/07/2026 | 24/07/2025 | 23/08/2024 | 25/10/2024 | 13/07/2022 | 31/08/2021 |
| General meeting | 06/05/2026 | 07/05/2025 | 02/05/2024 | 03/05/2023 | 04/05/2022 | 05/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
21 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 06/05/2026 | 01/07/2026 | French | |
| Abridged model | 31/12/2024 | 07/05/2025 | 24/07/2025 | French | |
| Abridged model | 31/12/2023 | 02/05/2024 | 23/08/2024 | French | |
| Abridged modelCorrection | 31/12/2022 | 03/05/2023 | 25/10/2024 | French | |
| Abridged model | 31/12/2022 | 03/05/2023 | 30/08/2023 | French | |
| Abridged model | 31/12/2021 | 04/05/2022 | 13/07/2022 | French | |
| Abridged model | 31/12/2020 | 05/05/2021 | 31/08/2021 | French | |
| Abridged model | 31/12/2019 | 06/05/2020 | 30/06/2020 | French | |
| Micro model | 31/12/2018 | 02/05/2019 | 29/08/2019 | French | |
| Abridged model | 31/12/2017 | 02/05/2018 | 13/08/2018 | French | |
| Abridged model | 31/12/2016 | 03/05/2017 | 06/07/2017 | French | |
| Abridged model | 31/12/2015 | 04/05/2016 | 30/08/2016 | French | |
| Abridged model | 31/12/2014 | 06/05/2015 | 24/08/2015 | French | |
| Abridged model | 31/12/2013 | 07/05/2014 | 15/09/2014 | French | |
| Abridged model | 31/12/2012 | 02/05/2013 | 29/08/2013 | French | |
| Abridged model | 31/12/2011 | 02/05/2012 | 27/06/2012 | French | |
| Abridged model | 31/12/2010 | 04/05/2011 | 31/08/2011 | French | |
| Abridged model | 31/12/2009 | 05/05/2010 | 24/08/2010 | French | |
| Abridged model | 31/12/2008 | 06/05/2009 | 28/08/2009 | French | |
| Abridged model | 31/12/2007 | 07/05/2008 | 26/08/2008 | French | |
| Abridged model | 31/12/2006 | 02/05/2007 | 11/09/2007 | French |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 1 active · 14 ended
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates24/01/2025SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Mandates18/03/2022DEMISSIONS, NOMINATIONS
- Mandates30/07/2021DEMISSIONS, NOMINATIONS
- Restructuring29/01/2019DENOMINATION - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring05/11/2018RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates02/07/2018DEMISSIONS, NOMINATIONS
- Capital / shares05/02/2018CAPITAL, ACTIONS
- Capital / shares20/01/2014CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202515,3 k €↑
- 2024Annual accounts 2024-25,2 k €↓
- 2023Annual accounts 2023-3,9 k €↑
- 2022Annual accounts 2022-4,1 k €↓
- 2021Annual accounts 202175 k €↑
- 2020Annual accounts 202016,9 k €↓
- 2019Annual accounts 201939,3 k €↓
- 2018Annual accounts 201882,9 k €↑
- 2018Name changeMAXPHARMA
- 2017Annual accounts 201711,6 k €↓
- 2016Annual accounts 201621,4 k €↑
- 2015Annual accounts 20158,3 k €↓
- 2014Annual accounts 201412,5 k €↓
- 2013Annual accounts 201313,6 k €↓
- 2012Annual accounts 201217,1 k €↓
- 2011Annual accounts 201127,9 k €↓
- 2010Annual accounts 201033,1 k €↑
- 2009Annual accounts 200921,2 k €↓
- 2008Annual accounts 200824,2 k €↑
- 2007Annual accounts 200714 k €↓
- 2006Annual accounts 200622 k €
- 2006Name changeGEHELULE
- 05/05/2000IncorporationPublic limited company